685 results on '"Baron, Jeffrey"'
Search Results
2. JAK2/mTOR inhibition fails to prevent acute GVHD despite reduced Th1/Th17 cells: final phase 2 trial results
3. Gemtuzumab ozogamicin plus standard induction chemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia
4. Bongga Ka Day: A Phenomenological Study on the Identity Formation and Work-Life Balance of Filipino Homosexual Male Breadwinners.
5. Navigating Glucagon-Like Peptide Receptor Agonist Reinitiation Amid Access Barriers: An Adverse Drug Event Case Report.
6. A neomorphic variant in SP7 alters sequence specificity and causes a high-turnover bone disorder
7. Outcomes of Adult Acute Myeloid Leukemia Treated With Gemtuzumab-Ozogamicin: Cue To Optimized Chemotherapy Backbone
8. A phase 2 trial of single low doses of rasburicase for treatment of hyperuricemia in adult patients with acute leukemia
9. DLG2 variants in patients with pubertal disorders
10. Persistent Sox9 expression in hypertrophic chondrocytes suppresses transdifferentiation into osteoblasts
11. Contributors
12. Disorders of Childhood Growth
13. Cartilage-Targeted IGF-1 Treatment to Promote Longitudinal Bone Growth
14. Defining the role of common variation in the genomic and biological architecture of adult human height
15. Identification of novel genes including NAV2 associated with isolated tall stature
16. Evaluation of Recipients of Positive and Negative Secondary Findings Evaluations in a Hybrid CLIA-Research Sequencing Pilot
17. Gemtuzumab ozogamicin plus standard induction hemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia
18. Epigenetic Causes of Overgrowth Syndromes
19. Genetics of Short Stature
20. Dexrazoxane for cardioprotection in older adults with acute myeloid leukemia
21. Effects of Estrogen on Growth Plate Senescence and Epiphyseal Fusion
22. Epigenetic Causes of Overgrowth Syndromes.
23. Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in Jehovah's witness patients
24. The Biology of Stature
25. HIV Infection
26. Empiric Therapy Based on Clinical Syndrome
27. Loss of function variant in SPIN4 causes an X-linked overgrowth syndrome
28. Concomitant Venetoclax and Imatinib for Comanaging Chronic Lymphocytic Leukemia and Chronic Myeloid Leukemia: A Case Report
29. Safety and efficacy of CPX-351 in younger patients (< 60 years) with secondary acute myeloid leukemia
30. MRD Status and ELN 2022 Predicts for Outcomes of Venetoclax + Hypomethylating Therapy in AML: Single-Center Real-World Analysis
31. Gemtuzumab Ozogamicin Plus Standard Induction Chemotherapy Improves Outcomes in Intermediate Risk Cytogenetic Acute Myeloid Leukemia
32. Safety and efficacy of CPX-351 in younger patients (
33. New developments in the genetic diagnosis of short stature
34. mir-374-5p, mir-379-5p, and mir-503-5p Regulate Proliferation and Hypertrophic Differentiation of Growth Plate Chondrocytes in Male Rats
35. Evidence that Igf2 down-regulation in postnatal tissues and up-regulation in malignancies is driven by transcription factor E2f3
36. Clinical Characterization of Patients With Autosomal Dominant Short Stature due to Aggrecan Mutations
37. Short and tall stature: a new paradigm emerges
38. Human Monoclonal Antibody Fragments Targeting Matrilin-3 in Growth Plate Cartilage
39. CNP-related short and tall stature: a close-knit family of growth disorders
40. Immunogenicity and Safety of Re-Exposure to Recombinant Human Thrombin in Surgical Hemostasis
41. HIV Infection
42. Spatial and temporal regulation of gene expression in the mammalian growth plate
43. Changes in gene expression associated with aging commonly originate during juvenile growth
44. Safety and Efficacy of CPX-351 in Younger Patients < 60 Years Old with Secondary Acute Myeloid Leukemia: An Updated Analysis
45. Midkine concentrations in fine-needle aspiration of benign and malignant thyroid nodules
46. Evidence That Up-Regulation of MicroRNA-29 Contributes to Postnatal Body Growth Deceleration
47. 11 - Disorders of Childhood Growth
48. Patterns of Human Growth
49. Evidence That the Etiology of Congenital Hypopituitarism Has a Major Genetic Component but Is Infrequently Monogenic
50. Inotuzumab Ozogamicin + Blinatumumab +/- Rituximab + Mini-Hcvd Shows Improved Tolerability with Similar Efficacy Compared to E1910 in Treatment of Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia in Older Adults
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.